| Electrostatically driven protein aggregation: β-lactoglobulin at low ionic strength PR Majhi, RR Ganta, RP Vanam, E Seyrek, K Giger, PL Dubin Langmuir 22 (22), 9150-9159, 2006 | 234 | 2006 |
| Regulation of membrane-cytoskeletal interactions by tyrosine phosphorylation of erythrocyte band 3 E Ferru, K Giger, A Pantaleo, E Campanella, J Grey, K Ritchie, R Vono, ... Blood 117 (22), 5998-6006, 2011 | 230 | 2011 |
| Suppression of insulin aggregation by heparin K Giger, RP Vanam, E Seyrek, PL Dubin Biomacromolecules 9 (9), 2338-2344, 2008 | 102 | 2008 |
| Unraveling Macrophage Heterogeneity in Erythroblastic Islands KG Seu, J Papoin, R Fessler, J Hom, G Huang, N Mohandas, L Blanc, ... Frontiers in Immunology 8, 1140, 2017 | 75 | 2017 |
| LIMK2 is a crucial regulator and effector of Aurora-A-kinase-mediated malignancy EO Johnson, KH Chang, S Ghosh, C Venkatesh, K Giger, PS Low, K Shah Journal of cell science 125 (5), 1204-1216, 2012 | 66 | 2012 |
| Inhibition of Band 3 tyrosine phosphorylation: a new mechanism for treatment of sickle cell disease P Noomuna, M Risinger, S Zhou, K Seu, Y Man, R An, DA Sheik, J Wan, ... British journal of haematology 190 (4), 599-609, 2020 | 46 | 2020 |
| Analysis of the mobilities of band 3 populations associated with ankyrin protein and junctional complexes in intact murine erythrocytes GC Kodippili, J Spector, J Hale, K Giger, MR Hughes, KM McNagny, ... Journal of Biological Chemistry 287 (6), 4129-4138, 2012 | 45 | 2012 |
| The spectrum of SPTA1-associated hereditary spherocytosis S Chonat, M Risinger, H Sakthivel, O Niss, JA Rothman, L Hsieh, ... Frontiers in physiology 10, 815, 2019 | 44 | 2019 |
| Cytokinesis failure in RhoA-deficient mouse erythroblasts involves actomyosin and midbody dysregulation and triggers p53 activation DG Konstantinidis, KM Giger, M Risinger, S Pushkaran, P Zhou, ... Blood 126 (12), 1473-1482, 2015 | 38 | 2015 |
| Dietary supplementation with docosahexanoic acid (DHA) increases red blood cell membrane flexibility in mice with sickle cell disease NJ Wandersee, JL Maciaszek, KM Giger, MS Hanson, S Zheng, YH Guo, ... Blood Cells, Molecules, and Diseases 54 (2), 183-188, 2015 | 32 | 2015 |
| Single-cell electrical lysis of erythrocytes detects deficiencies in the cytoskeletal protein network N Bao, GC Kodippili, KM Giger, VM Fowler, PS Low, C Lu Lab on a Chip 11 (18), 3053-3056, 2011 | 31 | 2011 |
| Etavopivat, a pyruvate kinase activator in red blood cells, for the treatment of sickle cell disease P Schroeder, K Fulzele, S Forsyth, MD Ribadeneira, S Guichard, E Wilker, ... Journal of Pharmacology and Experimental Therapeutics 380 (3), 210-219, 2022 | 27 | 2022 |
| VPS4A mutations in humans cause syndromic congenital dyserythropoietic anemia due to cytokinesis and trafficking defects KG Seu, LR Trump, S Emberesh, RB Lorsbach, C Johnson, J Meznarich, ... The American Journal of Human Genetics 107 (6), 1149-1156, 2020 | 25 | 2020 |
| Phylogenetic and ontogenetic view of erythroblastic islands KM Giger, TA Kalfa BioMed research international 2015, 2015 | 24 | 2015 |
| Erythroblastic islands foster granulopoiesis in parallel to terminal erythropoiesis L Romano, KG Seu, J Papoin, DE Muench, D Konstantinidis, A Olsson, ... Blood, The Journal of the American Society of Hematology 140 (14), 1621-1634, 2022 | 20 | 2022 |
| Diffusion of glycophorin A in human erythrocytes K Giger, I Habib, K Ritchie, PS Low Biochimica et Biophysica Acta (BBA)-Biomembranes 1858 (11), 2839-2845, 2016 | 17 | 2016 |
| Characterizing bulk rigidity of rigid red blood cell populations in sickle-cell disease patients M Gutierrez, M Shamoun, KG Seu, T Tanski, TA Kalfa, O Eniola-Adefeso Scientific Reports 11 (1), 1-10, 2021 | 15 | 2021 |
| Automated oxygen gradient ektacytometry: a novel biomarker in sickle cell anemia A Sadaf, KG Seu, E Thaman, R Fessler, DG Konstantinidis, HA Bonar, ... Frontiers in Physiology 12, 636609, 2021 | 14 | 2021 |
| Formation of complex three-dimensional structures in supported lipid bilayers K Giger, ER Lamberson, JS Hovis Langmuir 25 (1), 71-74, 2009 | 14 | 2009 |
| Ex-vivo FT-4202 treatment improves hemoglobin oxygen affinity and membrane health in red blood cells of patients with hemoglobin SS and hemoglobin SC disease irrespective of … DG Konstantinidis, R Fessler, KG Seu, B Patel, JB Korpik, K Fulzele, ... Blood 136, 23-24, 2020 | 9 | 2020 |
